These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24911669)

  • 1. Effectiveness of antiepileptic drug combination therapy for partial-onset seizures based on mechanisms of action.
    Margolis JM; Chu BC; Wang ZJ; Copher R; Cavazos JE
    JAMA Neurol; 2014 Aug; 71(8):985-93. PubMed ID: 24911669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States.
    Laliberté F; Duh MS; Barghout V; Germain G; Frech F; Plauschinat C; Lejeune D; Malhotra M; Faught E
    Epilepsy Behav; 2021 May; 118():107927. PubMed ID: 33812233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of background antiepileptic drugs on the efficacy and safety of pregabalin in treating partial-onset seizures: a post hoc analysis of combined clinical trials.
    Tomson T; Almas M; Giordano S; Cabrera J
    Epilepsy Res; 2011 Sep; 96(1-2):64-73. PubMed ID: 21624821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing treatment persistence in epilepsy: a comparative analysis of combined antiseizure medications with different mechanisms of action.
    Chang CW; Tseng WJ; Lin WR; Ko PC; Liu CJ; Lim SN
    Ther Adv Neurol Disord; 2023; 16():17562864231207161. PubMed ID: 37920860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
    Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
    Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis.
    Lee WC; Hoffmann MS; Arcona S; D'Souza J; Wang Q; Pashos CL
    Clin Ther; 2005 Oct; 27(10):1629-38. PubMed ID: 16330300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
    Chen SY; Wu N; Boulanger L; Sacco P
    J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
    Hansen RN; Nguyen HP; Sullivan SD
    Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
    Zachry WM; Doan QD; Clewell JD; Smith BJ
    Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing a new proof-of-principle trial for treatment of partial seizures to demonstrate efficacy with minimal sample size and duration-a case study.
    French JA; Cabrera J; Emir B; Whalen E; Lu F
    Epilepsy Res; 2013 Sep; 106(1-2):230-6. PubMed ID: 23727190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: description according to the 2009 ILAE definition of AED resistance (ESPERA study)].
    Vespignani H; de Zélicourt M; Laurendeau C; Fagnani F; Levy-Bachelot L; Murat C; Kahane P; de Toffol B
    Rev Neurol (Paris); 2014 Feb; 170(2):100-9. PubMed ID: 24439556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
    Elger CE; Brodie MJ; Anhut H; Lee CM; Barrett JA
    Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation and duration of antiepileptic drug therapy: a retrospective study of factors for specific epileptic syndromes.
    Kudo T; Nishida T; Yagi K
    Epilepsia; 2004; 45 Suppl 8():26-32. PubMed ID: 15610191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
    Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
    Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
    Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
    Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early add-on treatment vs alternative monotherapy in patients with partial epilepsy.
    Semah F; Thomas P; Coulbaut S; Derambure P
    Epileptic Disord; 2014 Jun; 16(2):165-74. PubMed ID: 24776953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.